Avalo Therapeutics Inc.

4.78
-0.10 (-2.05%)
At close: Apr 25, 2025, 3:59 PM
4.67
-2.30%
After-hours: Apr 25, 2025, 04:21 PM EDT

Avalo Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
441K 1.92M 18.05M 5.4M 6.7M 6.75M 18.33M 27.81M 1.15M
27.27M 1.28M 3.43M 1.49M 300K 11.63M 7.48M 635.65K 8.24M
-26.83M 640K 14.62M 3.91M 6.4M -4.88M 10.85M 27.18M -7.09M
-68.51M -23.44M -37.44M -82.13M -26.95M -17.39M -39.31M 13.89M -16.08M
n/a n/a 4.17M 2.39M 49K 121.33K n/a n/a n/a
-35.02M -31.53M -41.63M -84.55M -67.18M -15.99M -40.09M 13.84M -16.47M
-35.13M -31.54M -41.66M -84.35M -64.38M -16.27M -40.05M 11.87M -16.47M
17.24M 10.3M 20.71M 24.66M 19.76M 11.61M 19.2M 8.91M 7.08M
24.44M 13.78M 31.31M 59.84M 32.19M 11.76M 5.79M 4.37M 10.15M
n/a -23.44M 38K 1.55M 1.74M 1.34M 13.66K n/a n/a
41.68M 640K 52.06M 86.04M 53.69M 24.71M 29.52M 13.29M 17.23M
3.32M 3.42M 4.17M 2.39M n/a n/a n/a n/a n/a
n/a 33K 76K 2.83M 2.34M 1.48M 8.52M 973.35K n/a
68.95M 25.37M 55.49M 87.53M 53.99M 24.14M 37M 13.92M 17.23M
114K 14K 28K -196K -2.79M 280K -33.91K 1.97M 364.14K
8.13M 277.73K 39.2K 36.19K 25.51K 19.85K 12.07K 6.39K 3.07K
10.78M 277.73K 39.2K 36.19K 25.51K 19.85K 12.07K 6.51K 3.07K
-4.32 -113.58 -1.06K -2.33K -2.52K -819.74 -3.32K 1.86K -21.93
-3.26 -113.58 -1.06K -2.33K -2.52K -819.74 -3.32K 1.82K -21.93
-68.51M -27.95M -37.29M -80.5M -45.45M -17.36M -13.07M 14.35M -16.05M
-31.7M -28.11M -37.46M -82.15M -47.29M -17.39M -14.9M 13.89M -16.08M
n/a 158K 166K 1.66M 1.84M 1.46M 1.85M 425.48K 26.86K